New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

17Feb

Member Press Release - Revolutionise Your Pancreatic Elastase Testing with Alpha Labs

17 Feb, 2021 | Return|

Revolutionise Your Pancreatic Elastase Testing with the New BÜHLMANN fPELA® turbo
Faecal pancreatic elastase testing can now be automated, providing flexible and random access application on most clinical chemistry platforms. The new fPELA® turbo from BÜHLMANN is ideal for use in laboratory environments for identification and monitoring of pancreatic insufficiency in patients. There is the added advantage that it utilises the same CALEX extraction device as the fCAL turbo assay, so it is possible to run both tests from a single extract.

The fPELA technology is a milestone in automation of pancreatic elastase quantification. It reduces the hands-on time dramatically and allows reporting of pancreatic elastase results from human stool samples within the shortest time. Time to first result is just 10 minutes with further results following every few seconds thereafter, making it one of the fastest faecal elastase assays available.

Please visit www.alphalabs.co.uk/fpela to find out more about the fPELA® turbo, or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk 

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858